| Today's Open | $8.04 |
|---|---|
| Previous Close | $8.06 |
| Daily Range | $8.01 - $8.36 |
| 52-Week Range | $5.86 - $13.50 |
| Market Cap | $1.8B |
| P/E Ratio | -22.39 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 6,433,131 |
| Average Daily Volume | 5,273,699 |
| Current FY EPS | -$0.12 |
Sector
Healthcare
Industry
Drugs
Arena Pharmaceuticals, Inc. (ARNA) Description
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/
News & Commentary
A mixture of cultural and socioeconomic factors make these seven U.S. states the healthiest.
3 Pipeline Obesity Treatments You Should Watch
In the past year, two approved obesity drugs put the massive obesity market within reach of investors. Here are three treatments under development that could have even bigger consequences.The Surprising Link Between ADHD and Obesity
This disorder in childhood could put your adult health at risk.ARNA's Top Competitors
(2.99%)
(0.27%)
(0.59%)
(1.13%)